These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 18203441)

  • 1. Exosome nanovesicles displaying G protein-coupled receptors for drug discovery.
    Estelles A; Sperinde J; Roulon T; Aguilar B; Bonner C; LePecq JB; Delcayre A
    Int J Nanomedicine; 2007; 2(4):751-60. PubMed ID: 18203441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exosome Display technology: applications to the development of new diagnostics and therapeutics.
    Delcayre A; Estelles A; Sperinde J; Roulon T; Paz P; Aguilar B; Villanueva J; Khine S; Le Pecq JB
    Blood Cells Mol Dis; 2005; 35(2):158-68. PubMed ID: 16087368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of exosome surface display technology in living human cells.
    Stickney Z; Losacco J; McDevitt S; Zhang Z; Lu B
    Biochem Biophys Res Commun; 2016 Mar; 472(1):53-9. PubMed ID: 26902116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stabilization of exosome-targeting peptides via engineered glycosylation.
    Hung ME; Leonard JN
    J Biol Chem; 2015 Mar; 290(13):8166-72. PubMed ID: 25657008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell-Derived Nanovesicles as Exosome-Mimetics for Drug Delivery Purposes: Uses and Recommendations.
    Ou YH; Zou S; Goh WJ; Wang JW; Wacker M; Czarny B; Pastorin G
    Methods Mol Biol; 2021; 2211():147-170. PubMed ID: 33336276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Affinity biosensors using recombinant native membrane proteins displayed on exosomes: application to botulinum neurotoxin B receptor.
    Desplantes R; Lévêque C; Muller B; Lotierzo M; Ferracci G; Popoff M; Seagar M; Mamoun R; El Far O
    Sci Rep; 2017 Apr; 7(1):1032. PubMed ID: 28432329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subtypes of the somatostatin receptor assemble as functional homo- and heterodimers.
    Rocheville M; Lange DC; Kumar U; Sasi R; Patel RC; Patel YC
    J Biol Chem; 2000 Mar; 275(11):7862-9. PubMed ID: 10713101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Virus-mimetic nanovesicles as a versatile antigen-delivery system.
    Zhang P; Chen Y; Zeng Y; Shen C; Li R; Guo Z; Li S; Zheng Q; Chu C; Wang Z; Zheng Z; Tian R; Ge S; Zhang X; Xia NS; Liu G; Chen X
    Proc Natl Acad Sci U S A; 2015 Nov; 112(45):E6129-38. PubMed ID: 26504197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Somatostatin displayed on filamentous phage as a receptor-specific agonist.
    Rousch M; Lutgerink JT; Coote J; de Bruïne A; Arends JW; Hoogenboom HR
    Br J Pharmacol; 1998 Sep; 125(1):5-16. PubMed ID: 9776337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A human somatostatin receptor (SSTR3), located on chromosome 22, displays preferential affinity for somatostatin-14 like peptides.
    Corness JD; Demchyshyn LL; Seeman P; Van Tol HH; Srikant CB; Kent G; Patel YC; Niznik HB
    FEBS Lett; 1993 Apr; 321(2-3):279-84. PubMed ID: 8097479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunochemical strategy for quantification of G-coupled olfactory receptor proteins on natural nanovesicles.
    Sanmartí-Espinal M; Galve R; Iavicoli P; Persuy MA; Pajot-Augy E; Marco MP; Samitier J
    Colloids Surf B Biointerfaces; 2016 Mar; 139():269-76. PubMed ID: 26724468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BCR-bound antigen is targeted to exosomes in human follicular lymphoma B-cells.
    Rialland P; Lankar D; Raposo G; Bonnerot C; Hubert P
    Biol Cell; 2006 Aug; 98(8):491-501. PubMed ID: 16677129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exosome Theranostics: Biology and Translational Medicine.
    He C; Zheng S; Luo Y; Wang B
    Theranostics; 2018; 8(1):237-255. PubMed ID: 29290805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exosome-Mimetic Nanovesicles from Hepatocytes promote hepatocyte proliferation in vitro and liver regeneration in vivo.
    Wu JY; Ji AL; Wang ZX; Qiang GH; Qu Z; Wu JH; Jiang CP
    Sci Rep; 2018 Feb; 8(1):2471. PubMed ID: 29410409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic Evolution of Ligands by Exosome Enrichment: A Proof-of-Concept Study for Exosome-Based Targeting Peptide Screening.
    Liu X; Yang X; Sun W; Wu Q; Song Y; Yuan L; Yang G
    Adv Biosyst; 2019 Feb; 3(2):e1800275. PubMed ID: 32627374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipid Nanovesicles by Microfluidics: Manipulation, Synthesis, and Drug Delivery.
    Liu C; Feng Q; Sun J
    Adv Mater; 2019 Nov; 31(45):e1804788. PubMed ID: 30570773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Engineering exosomes for targeted drug delivery.
    Liang Y; Duan L; Lu J; Xia J
    Theranostics; 2021; 11(7):3183-3195. PubMed ID: 33537081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterisation of the fish sst3 receptor, a member of the SRIF1 receptor family: atypical pharmacological features.
    Siehler S; Zupanc GK; Seuwen K; Hoyer D
    Neuropharmacology; 1999 Mar; 38(3):449-62. PubMed ID: 10219983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and expression of soluble CTLA-4 variable domain as a scaffold for the display of functional polypeptides.
    Nuttall SD; Rousch MJ; Irving RA; Hufton SE; Hoogenboom HR; Hudson PJ
    Proteins; 1999 Aug; 36(2):217-27. PubMed ID: 10398368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioinspired exosome-mimetic nanovesicles for targeted delivery of chemotherapeutics to malignant tumors.
    Jang SC; Kim OY; Yoon CM; Choi DS; Roh TY; Park J; Nilsson J; Lötvall J; Kim YK; Gho YS
    ACS Nano; 2013 Sep; 7(9):7698-710. PubMed ID: 24004438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.